Compound Detail
CHEMBL473
DOFETILIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL473 |
| Name | DOFETILIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IXTMWRCNAAVVAI-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
3
Targets
34
Activities
2
Assay Types
27
PK Parameters
20
Publications
5
Known Names
6
Indications
1
Mechanisms
Molecular Properties
441.6
MW (Da)
1.98
ALogP
6
HBA
2
HBD
104.8
PSA (Ų)
0.55
QED
0
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1999 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| HERG blocker | BLOCKER | Voltage-gated inwardly rectifying potassium channel KCNH2 | ✓ | ✓ |
Indications
Arrhythmias, Cardiac Arrhythmias, Cardiac Atrial Fibrillation Atrial Flutter Heart Failure Romano-Ward Syndrome
ATC Classification
C01BD04
dofetilide
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Drug Warnings
Black Box Warning
cardiotoxicity
Activity Summary
IC50 32 meas. best 8.39
Ki 2 meas. best 8.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 8.39 | 7.4238 | 4.1 | 21 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | Ki | 8.19 | 8.15 | 6.4 | 2 |
| T-cell line CHEMBL614685 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Voltage-gated L-type calcium channel CHEMBL2095229 | IC50 | 4.57 | 4.395 | 26700.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 6.49 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 3.73 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 0.95 | mL.min-1.g-1 | Canis lupus familiaris |
| CL | 0.25 | mL.min-1.g-1 | Homo sapiens |
| CL | 13.16 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 7.57 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 1.93 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 0.51 | mL.min-1.kg-1 | Homo sapiens |
| CL | 39.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 22.7 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 5.8 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 1.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.2 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 5.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.68 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 13.18 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| F | 80.0 | % | Homo sapiens |
| F | 72.0 | % | Canis lupus familiaris |
| F | 100.0 | % | Homo sapiens |
| Fu | 0.36 | - | Homo sapiens |
| Fu | 0.36 | - | Homo sapiens |
| MRT | 11.0 | hr | Homo sapiens |
| T1/2 | 4.0 | hr | - |
| T1/2 | 8.1 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine